CClinicalTrials.gg
RecruitingNCT05840900MORPHEUpdated Aug 24, 2025

Mindfulness, Optimism, and Resilience for Perinatal Health and Equity Study

An interventional study of Digital Mindfulness Training in Postpartum Psychiatric Disorders, sponsored by Nina Ayala. Recruiting at 2 sites in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-08-24.

Sponsored by Nina Ayala · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Feb 2024; still recruiting 2 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Dispositional optimism (the general assumption that more good things than bad will occur across various life domains) has been tied to improved somatic and mental health outcomes. Dispositional optimism is malleable, although prior interventions have been time and resource intensive and thus are not well-tailored to the peripartum period. The purpose of this pilot study is to evaluate the feasibility and acceptability of a pregnancy-oriented mindfulness phone application (Expectful) versus standard care among first-time mothers with low dispositional optimism in early pregnancy. Other aims include evaluating the impact of Expectful use on dispositional optimism, adverse pregnancy outcomes (cesarean delivery, hypertensive disorders of pregnancy, and gestational diabetes) and postpartum post-traumatic stress symptoms.

Read the detailed description

This randomized clinical trial of nulliparous women with low dispositional optimism in early pregnancy seeks to determine whether use of a pregnancy-oriented digital mindfulness application will be feasible and acceptable and show preliminary evidence of efficacy in improving dispositional optimism, reducing adverse perinatal outcomes and improving postpartum post-traumatic stress symptoms.

This pilot will include 100 women recruited from the obstetrical service at Women and Infants Hospital of Rhode Island. Women will be included if they are nulliparous, have a singleton pregnancy at \<20 weeks gestational age, speak English and have low dispositional optimism (a score of ≤14 on the validated, Revised Life Orientation Test). Eligible participants will be randomized to either using the digital app Expectful or standard pregnancy care.

Women will be randomized with equal probability to the intervention group using block randomization stratified by race/ethnicity (Hispanic, non-Hispanic White/Other or non-Hispanic Black).

Women in the mindfulness training arm will complete 8 weeks of daily mindfulness training exercises using Expectful. Women in the standard care group will receive standard pregnancy and postpartum care. Pregnancy and labor management will be at the discretion of each participant's obstetric provider.

Participants in both groups will be asked to complete 4 questionnaires: one at enrollment, a post-intervention one at 8 weeks, at the time of delivery and at 6-8 weeks postpartum. Half of the participants in each arm (total n=50), will be asked to complete a qualitative, semi-structured interview on the role of optimism and other resilience factors in pregnancy.

02

Conditions studied

  • Postpartum Psychiatric Disorders

Keywords

  • dispositional optimism
  • mindfulness
  • adverse perinatal outcomes
03

In context

Lead sponsor

This is the only study on the registry with Nina Ayala as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Able to provide informed consent
  • English speaking
  • Nulliparous (no prior delivery at or greater than 20w0d gestation)
  • Pregnant with singleton fetus
  • \<20w0d gestation
  • Low dispositional optimism (score \</= 14 on the Revised Life Orientation Test)
  • Owns a smart phone

Exclusion criteria

Exclusion Criteria:

  • Plan to deliver at another institution
  • Ongoing (≥1/week) mind-body practice including mindfulness training, meditation or yoga
  • Pre-gestational hypertensive disorder
  • Pre-gestational diabetes mellitus
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    App-based mindfulness training

    App-based daily mindfulness training Standard prenatal and pregnancy care

    Behavioral: Digital Mindfulness Training

  • No intervention
    Usual Care

    Standard prenatal and pregnancy care

Interventions

  • BehavioralDigital Mindfulness Training

    Once daily, 5-10 minute mindfulness exercises for 8 week intervention period using the existing perinatal mindfulness application Expectful

06

What researchers measure

Primary outcomes

  1. Percentage of participants completing the assigned mindfulness exercises

    The intervention will be considered feasible if ≥75% participants complete \>50% of the assigned daily mindfulness exercises over the 8-week intervention period

    Time frame: 8-week intervention period

  2. Intervention acceptability

    The intervention will be considered acceptable if ≥75% report "satisfied" or "very satisfied" on a post-intervention consumer satisfaction survey with a 5-point Likert scale from very unsatisfied to very satisfied.

    Time frame: After 8 week intervention period, approximately 16-28 weeks gestation.

Secondary outcomes

  1. Dispositional optimism

    Change in dispositional optimism score (on validated Revised Life Orientation Test, scale range 0-24, higher scores indicate higher optimism) between enrollment and postpartum assessments

    Time frame: Study enrollment and 6-12 weeks postpartum

  2. Cesarean delivery

    Binary yes/no

    Time frame: Delivery

  3. Hypertensive disorder of pregnancy

    Binary yes/no; includes gestational hypertension, pre-eclampsia with or without severe features, HELLP syndrome or eclampsia

    Time frame: 6-12 weeks postpartum

  4. Gestational diabetes mellitus

    Binary yes/no

    Time frame: Delivery

  5. Preterm birth

    Binary yes/no; Delivery between 20w0d and 36w6d gestation

    Time frame: Delivery

  6. Traumatic birth

    Binary yes/no; Self-reported experience of birth as traumatic given concern for life or well-being of self or infant

    Time frame: Delivery

  7. Postpartum post-traumatic stress symptoms

    Continuous scale score using the PTSD Checklist for the Diagnostic and Statistical Manual of Mental Disorders (PCL-5, scale range 0-80, higher scores indicate worse post-traumatic stress symptoms)

    Time frame: 6-12 weeks postpartum

07

Study locations

2 of 2 sites recruiting
  • Obstetrics and Gynecology Care Center
    Providence, Rhode Island 02905, United States
    • Nina K. Ayala, MD · Contact
    Recruiting
  • Prenatal Diagnosis Center
    Providence, Rhode Island 02905, United States
    • Nina K. Ayala, MD · Contact
    Recruiting
08

References and documents

Publications

  • Chang E, Lewkowitz AK, Unger JA, Garfield CF, Miller ES. Smartphone Applications to Support Perinatal Mental Health. Obstet Gynecol. 2026 Feb 1;147(2):229-238. doi: 10.1097/AOG.0000000000006139. Epub 2025 Dec 18. PubMed 41411652 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05840900
Lead sponsor
Nina Ayala
Collaborators
The Miriam Hospital
Responsible party
Nina Ayala (Attending Physician, Maternal-Fetal Medicine, Women and Infants Hospital of Rhode Island) — Sponsor-investigator
First posted
May 3, 2023
Start date
Feb 20, 2024
Primary completion
Apr 1, 2026 (estimated)
Completion
Oct 1, 2026 (estimated)
Last update
Aug 24, 2025

Study contacts

Nina K Ayala, MD, MSCR
Contact
nayala@carene.org
401-274-1100 ext. 43435
Emily S Miller, MD, MPH
Contact
emmiller@carene.org
401-274-1100 ext. 47452

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion